Long-lived Plasma Cells in Immunity and Inflammation
Overview
Authors
Affiliations
Vitalle J, Zenarruzabeitia O, Merino-Perez A, Terren I, Orrantia A, Pacho de Lucas A Int J Mol Sci. 2023; 24(18).
PMID: 37762055 PMC: 10530418. DOI: 10.3390/ijms241813754.
Multiple Myeloma: Available Therapies and Causes of Drug Resistance.
Pinto V, Bergantim R, Caires H, Seca H, Guimaraes J, Vasconcelos M Cancers (Basel). 2020; 12(2).
PMID: 32050631 PMC: 7072128. DOI: 10.3390/cancers12020407.
Fernandez T, Gomez E, Dona I, Campo P, Rondon C, Gonzalez M Sci Rep. 2015; 5:14482.
PMID: 26416023 PMC: 4586444. DOI: 10.1038/srep14482.
Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity.
Beesu M, Caruso G, Salyer A, Khetani K, Sil D, Weerasinghe M J Med Chem. 2015; 58(19):7833-49.
PMID: 26351878 PMC: 4601487. DOI: 10.1021/acs.jmedchem.5b01087.
Pathogenesis beyond the cancer clone(s) in multiple myeloma.
Bianchi G, Munshi N Blood. 2015; 125(20):3049-58.
PMID: 25838343 PMC: 4432002. DOI: 10.1182/blood-2014-11-568881.